Because GRK2 levels and activity have been reported to be enhanced in obesity and insulin resistance (24), in future studies it will be important to evaluate whether GRK inhibition enhances the effect of DPP-4. The gene discussed is DPP4; the disease is obesity due to melanocortin 4 receptor deficiency.